Document Detail


Study of septic shock in the non-human primate: relationship of pathophysiological response to therapy with anti-TNF antibody.
MedLine Citation:
PMID:  7628065     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Therapy with anti-TNF antibody is reported to be effective in preventing morbidity and mortality in baboons given lethal infusions of Escherichia coli. Treated animals survived, and organ histopathology was absent when antibody was administered early after lethal infusions of E. coli. The present study explored the relationship between antibody dosage, pathophysiology, and survivability from shock. When antibody dose was decreased lungs, kidneys, adrenals, spleen, and liver were injured as shown by increased vascular congestion, hemorrhage, edema, and necrosis of tissues. Survival was also affected. All animals treated with 15 mg/kg antibody survived as reported earlier; less than 60% survived with 7.5 mg/kg; 9% survived with 5.0 mg/kg, and all died with 1.5 mg/kg. Serum concentrations of interleukin-6 (IL-6) increased markedly as dose of antibody decreased. The increases in concentrations of IL-6 were associated with increases in morbidity and mortality following E. coli administration.
Authors:
L B Hinshaw; T E Emerson; A C Chang; M Duerr; G Peer; M Fournel
Related Documents :
2412215 - The influence of copper-dextran complex (c-79), non-steroid anti-inflammatory drugs and...
9710945 - Protective effects of interleukin-10 on diaphragm muscle in a septic animal model.
8131165 - Effects of hepatic artery embolization with lipiodol and gelatin sponge particles on no...
12728305 - Nicotinamide increases systemic vascular resistance in ovine endotoxemia.
3763665 - Variable interval schedules of timeout from avoidance: effects of ethanol, naltrexone, ...
9219835 - Photodynamic activities and biodistribution of fluorinated zinc phthalocyanine derivati...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Circulatory shock     Volume:  44     ISSN:  0092-6213     ISO Abbreviation:  Circ. Shock     Publication Date:  1994 Dec 
Date Detail:
Created Date:  1995-09-07     Completed Date:  1995-09-07     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0414112     Medline TA:  Circ Shock     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  221-9     Citation Subset:  IM    
Affiliation:
Free Radical Biology and Aging Research Program, Oklahoma Medical Research Foundation, Oklahoma City 73104, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenal Glands / pathology
Animals
Antibodies, Monoclonal / administration & dosage
Dose-Response Relationship, Immunologic
Escherichia coli Infections
Immunotherapy*
Interleukin-6 / metabolism
Kidney / pathology
Liver / pathology
Lung / pathology
Papio
Shock, Septic / mortality,  pathology,  therapy*
Spleen / pathology
Survival Rate
Tumor Necrosis Factor-alpha / immunology*,  metabolism
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Interleukin-6; 0/Tumor Necrosis Factor-alpha

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pentoxifylline inhibits mediator synthesis in an equine in vitro whole blood model of endotoxemia.
Next Document:  Beta-hexosaminidase: biosynthesis and processing of the normal enzyme, and identification of mutatio...